nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.179	0.218	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.12	0.146	CbGbCtD
Carbamazepine—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.12	0.146	CbGbCtD
Carbamazepine—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0899	0.109	CbGbCtD
Carbamazepine—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0864	0.105	CbGbCtD
Carbamazepine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0725	0.0882	CbGbCtD
Carbamazepine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0603	0.0734	CbGbCtD
Carbamazepine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0585	0.0712	CbGbCtD
Carbamazepine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.035	0.0427	CbGbCtD
Carbamazepine—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.00632	0.0448	CcSEcCtD
Carbamazepine—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.035	CcSEcCtD
Carbamazepine—Non-Hodgkin's lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.00472	0.0335	CcSEcCtD
Carbamazepine—Lymphoma—Cyclosporine—focal segmental glomerulosclerosis	0.00472	0.0335	CcSEcCtD
Carbamazepine—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.00452	0.032	CcSEcCtD
Carbamazepine—Thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.0249	CcSEcCtD
Carbamazepine—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00346	0.0246	CcSEcCtD
Carbamazepine—SCN9A—nephron tubule—focal segmental glomerulosclerosis	0.00331	0.0911	CbGeAlD
Carbamazepine—RALBP1—nephron tubule—focal segmental glomerulosclerosis	0.00321	0.0881	CbGeAlD
Carbamazepine—Azotaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.0219	CcSEcCtD
Carbamazepine—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.0201	CcSEcCtD
Carbamazepine—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.0201	CcSEcCtD
Carbamazepine—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.0201	CcSEcCtD
Carbamazepine—UGT2B7—kidney—focal segmental glomerulosclerosis	0.00282	0.0775	CbGeAlD
Carbamazepine—RALBP1—kidney—focal segmental glomerulosclerosis	0.00282	0.0775	CbGeAlD
Carbamazepine—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00281	0.0773	CbGeAlD
Carbamazepine—RALBP1—cortex of kidney—focal segmental glomerulosclerosis	0.00274	0.0754	CbGeAlD
Carbamazepine—SCN4A—kidney—focal segmental glomerulosclerosis	0.0026	0.0714	CbGeAlD
Carbamazepine—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.0178	CcSEcCtD
Carbamazepine—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.0175	CcSEcCtD
Carbamazepine—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00241	0.0662	CbGeAlD
Carbamazepine—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.0127	CcSEcCtD
Carbamazepine—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00173	0.0123	CcSEcCtD
Carbamazepine—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.00172	0.0473	CbGeAlD
Carbamazepine—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0111	CcSEcCtD
Carbamazepine—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.011	CcSEcCtD
Carbamazepine—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0107	CcSEcCtD
Carbamazepine—ABCC2—kidney—focal segmental glomerulosclerosis	0.00151	0.0415	CbGeAlD
Carbamazepine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.0107	CcSEcCtD
Carbamazepine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.0105	CcSEcCtD
Carbamazepine—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.00147	0.0405	CbGeAlD
Carbamazepine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.0101	CcSEcCtD
Carbamazepine—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00995	CcSEcCtD
Carbamazepine—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00967	CcSEcCtD
Carbamazepine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00949	CcSEcCtD
Carbamazepine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00949	CcSEcCtD
Carbamazepine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00949	CcSEcCtD
Carbamazepine—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.00944	CcSEcCtD
Carbamazepine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00923	CcSEcCtD
Carbamazepine—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00892	CcSEcCtD
Carbamazepine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00888	CcSEcCtD
Carbamazepine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00881	CcSEcCtD
Carbamazepine—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.0087	CcSEcCtD
Carbamazepine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00866	CcSEcCtD
Carbamazepine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00849	CcSEcCtD
Carbamazepine—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00116	0.032	CbGeAlD
Carbamazepine—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.00116	0.0318	CbGeAlD
Carbamazepine—CYP2C8—kidney—focal segmental glomerulosclerosis	0.00113	0.0312	CbGeAlD
Carbamazepine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00764	CcSEcCtD
Carbamazepine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00749	CcSEcCtD
Carbamazepine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00734	CcSEcCtD
Carbamazepine—CYP3A5—kidney—focal segmental glomerulosclerosis	0.00102	0.0281	CbGeAlD
Carbamazepine—CYP2B6—kidney—focal segmental glomerulosclerosis	0.00102	0.028	CbGeAlD
Carbamazepine—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00719	CcSEcCtD
Carbamazepine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00715	CcSEcCtD
Carbamazepine—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000996	0.0274	CbGeAlD
Carbamazepine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000995	0.00706	CcSEcCtD
Carbamazepine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000992	0.00703	CcSEcCtD
Carbamazepine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000956	0.00678	CcSEcCtD
Carbamazepine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000941	0.00668	CcSEcCtD
Carbamazepine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000933	0.00662	CcSEcCtD
Carbamazepine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000928	0.00658	CcSEcCtD
Carbamazepine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000922	0.00654	CcSEcCtD
Carbamazepine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000922	0.00654	CcSEcCtD
Carbamazepine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00092	0.00652	CcSEcCtD
Carbamazepine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000907	0.00643	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000904	0.00641	CcSEcCtD
Carbamazepine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000899	0.00638	CcSEcCtD
Carbamazepine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000899	0.00638	CcSEcCtD
Carbamazepine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000897	0.00636	CcSEcCtD
Carbamazepine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000897	0.00636	CcSEcCtD
Carbamazepine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000879	0.00624	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000872	0.00619	CcSEcCtD
Carbamazepine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000865	0.00614	CcSEcCtD
Carbamazepine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00083	0.00589	CcSEcCtD
Carbamazepine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000828	0.00587	CcSEcCtD
Carbamazepine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000822	0.00583	CcSEcCtD
Carbamazepine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000818	0.0058	CcSEcCtD
Carbamazepine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000814	0.00577	CcSEcCtD
Carbamazepine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000812	0.00576	CcSEcCtD
Carbamazepine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000772	0.00547	CcSEcCtD
Carbamazepine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000768	0.00545	CcSEcCtD
Carbamazepine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000768	0.0211	CbGeAlD
Carbamazepine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000751	0.00533	CcSEcCtD
Carbamazepine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000746	0.00529	CcSEcCtD
Carbamazepine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000743	0.00527	CcSEcCtD
Carbamazepine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00074	0.00525	CcSEcCtD
Carbamazepine—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000732	0.00519	CcSEcCtD
Carbamazepine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000725	0.00514	CcSEcCtD
Carbamazepine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000721	0.00511	CcSEcCtD
Carbamazepine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000707	0.00502	CcSEcCtD
Carbamazepine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000706	0.00501	CcSEcCtD
Carbamazepine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.0007	0.00496	CcSEcCtD
Carbamazepine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000693	0.00491	CcSEcCtD
Carbamazepine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000679	0.00482	CcSEcCtD
Carbamazepine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000675	0.00479	CcSEcCtD
Carbamazepine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000666	0.00472	CcSEcCtD
Carbamazepine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000662	0.0047	CcSEcCtD
Carbamazepine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00467	CcSEcCtD
Carbamazepine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000648	0.00459	CcSEcCtD
Carbamazepine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000645	0.00458	CcSEcCtD
Carbamazepine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000624	0.00443	CcSEcCtD
Carbamazepine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000622	0.00441	CcSEcCtD
Carbamazepine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000618	0.017	CbGeAlD
Carbamazepine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.00435	CcSEcCtD
Carbamazepine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.00435	CcSEcCtD
Carbamazepine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.00435	CcSEcCtD
Carbamazepine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000612	0.00434	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000609	0.00432	CcSEcCtD
Carbamazepine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.0006	0.00426	CcSEcCtD
Carbamazepine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000593	0.00421	CcSEcCtD
Carbamazepine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000588	0.00417	CcSEcCtD
Carbamazepine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000588	0.00417	CcSEcCtD
Carbamazepine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000584	0.00414	CcSEcCtD
Carbamazepine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000577	0.00409	CcSEcCtD
Carbamazepine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.00408	CcSEcCtD
Carbamazepine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000571	0.00405	CcSEcCtD
Carbamazepine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000569	0.00403	CcSEcCtD
Carbamazepine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.00398	CcSEcCtD
Carbamazepine—ABCB1—kidney—focal segmental glomerulosclerosis	0.000543	0.0149	CbGeAlD
Carbamazepine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000536	0.0038	CcSEcCtD
Carbamazepine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000532	0.00377	CcSEcCtD
Carbamazepine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000529	0.0146	CbGeAlD
Carbamazepine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000528	0.00375	CcSEcCtD
Carbamazepine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000524	0.00372	CcSEcCtD
Carbamazepine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000523	0.00371	CcSEcCtD
Carbamazepine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.00367	CcSEcCtD
Carbamazepine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000511	0.00363	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000508	0.0036	CcSEcCtD
Carbamazepine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000507	0.0036	CcSEcCtD
Carbamazepine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00357	CcSEcCtD
Carbamazepine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.00357	CcSEcCtD
Carbamazepine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000485	0.00344	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000481	0.00341	CcSEcCtD
Carbamazepine—Magnesium salicylate—ALB—focal segmental glomerulosclerosis	0.000478	0.505	CrCbGaD
Carbamazepine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000467	0.00331	CcSEcCtD
Carbamazepine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000465	0.0033	CcSEcCtD
Carbamazepine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000465	0.0033	CcSEcCtD
Carbamazepine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000433	0.00307	CcSEcCtD
Carbamazepine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000422	0.00299	CcSEcCtD
Carbamazepine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000416	0.00295	CcSEcCtD
Carbamazepine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000402	0.00285	CcSEcCtD
Carbamazepine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000389	0.00276	CcSEcCtD
Carbamazepine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000374	0.00265	CcSEcCtD
Carbamazepine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000371	0.00263	CcSEcCtD
Carbamazepine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000371	0.00263	CcSEcCtD
Carbamazepine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000369	0.00261	CcSEcCtD
Carbamazepine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000349	0.00248	CcSEcCtD
Carbamazepine—Oxcarbazepine—ALB—focal segmental glomerulosclerosis	0.000282	0.298	CrCbGaD
Carbamazepine—Phenytoin—ALB—focal segmental glomerulosclerosis	0.000187	0.197	CrCbGaD
